Name Downloads Version Owner Last Modified Rating
Name Downloads Version Owner Last Modified Rating
Publications
Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort
374 downloads 1.1 EPAD Administrator3 06-04-2021
Assessing and disclosing test results for ‘mild cognitive impairment’ the perspective of old age psychiatrists in Scotland
90 downloads 1.0 EPAD Administrator3 17-01-2022
Associations Between Multimorbidity and Cerebrospinal Fluid Amyloid: A Cross-Sectional Analysis of the European Prevention of Alzheimer’s Dementia (EPAD) V500.0 Cohort
794 downloads 1.1 EPAD Administrator3 16-08-2019
At, with and beyond risk: expectations of living with the possibility of future dementia
1065 downloads 1.1 EPAD Administrator3 16-04-2018
Brain Amyloid Pathology and Cognitive Function Alzheimer Disease Without Dementia?
1630 downloads 1.0.1 EPAD Administrator3 13-06-2017
Cognitive Dispersion is not Associated with Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Results from the European Prevention of Alzheimer’s Dementia (EPAD) v500.0 Cohort
450 downloads 1.1 EPAD Administrator3 11-09-2020
Cognitive Functions as Predictors of Alzheimer’s Disease Biomarker Status in the European Prevention of Alzheimer’s Dementia Cohort
641 downloads 1.1 EPAD Administrator3 05-03-2020
Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility
1836 downloads 1.1 01-10-2016
Development of interventions for the secondary prevention of Alzheimer’s dementia: the European Prevention of Alzheimer’s Dementia (EPAD) project
1762 downloads 1.0 09-12-2015
Disease Modelling of Cognitive Outcomes and Biomarkers in the European Prevention of Alzheimer’s Dementia Longitudinal Cohort
186 downloads 1.0 EPAD Administrator3 20-08-2021
Ethical Arguments Concerning the Use of Alzheimer's Disease Biomarkers in Individuals with No or Mild Cognitive Impairment: A Systematic Review and Framework for Discussion
775 downloads 1.1 EPAD Administrator3 12-12-2018
Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit
1355 downloads 1.0 EPAD Administrator3 15-03-2016
Ethical issues in the development of readiness cohorts in Alzheimer’s disease research
1440 downloads 1.0 EPAD Administrator3 22-02-2017
European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials
963 downloads 1.1 EPAD Administrator3 28-03-2018
European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol
990 downloads 1.0 EPAD Administrator3 27-12-2018
Evaluating the Alzheimer's disease data landscape
352 downloads 1.0 EPAD Administrator3 16-12-2020
Evolution and future directions for the concept of mild cognitive impairment
1055 downloads 1.0 EPAD Administrator3 13-12-2017
Involving research participants in a pan-European research initiative: the EPAD participant panel experience
367 downloads 1.1 EPAD Administrator3 27-10-2020
Lived time and the affordances of clinical research participation
96 downloads 1.0 EPAD Administrator3 14-01-2022
Medial temporal lobe atrophy and posterior atrophy scales normative values
673 downloads 1.0 EPAD Administrator3 15-07-2019
Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease
693 downloads 1.0 EPAD Administrator3 23-07-2019
On the personal utility of Alzheimer’s disease-related biomarker testing in the research context
970 downloads 1.0 EPAD Administrator3 29-08-2018
Perspectives on Communicating Biomarker-Based Assessments of Alzheimer’s Disease to Cognitively Healthy Individuals
907 downloads 1.0 EPAD Administrator3 20-02-2018
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease‐modifying therapies
388 downloads 1.0 EPAD Administrator3 20-08-2020
Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals: results from the EPAD longitudinal cohort study
413 downloads 1.0 EPAD Administrator3 09-11-2020
Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings
615 downloads 1.0 EPAD Administrator3 06-01-2020
Psychological, behavioral and social effects of disclosing Alzheimer’s disease biomarkers to research participants: a systematic review
1441 downloads 1.0 10-11-2016
Re-aligning scientific and lay narratives of Alzheimer's disease
585 downloads 1.0 EPAD Administrator3 01-10-2019
Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project
1672 downloads 1.1 01-10-2016
Research participants as collaborators: Background, experience and policies from the PREVENT Dementia and EPAD programmes
935 downloads 1.1 EPAD Administrator3 29-10-2018
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
901 downloads 1.0 EPAD Administrator3 30-10-2018
The European Prevention of Alzheimer’s Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0
627 downloads 1.0 EPAD Administrator3 26-11-2019
The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in eight countries
312 downloads 1.0 EPAD Administrator3 13-05-2020
The Rationale Behind the New Alzheimer’s Disease Conceptualization: Lessons Learned During the Last Decades
932 downloads 1.0 EPAD Administrator3 13-03-2018
The relation between APOE genotype and cerebral microbleeds in cognitively unimpaired middle- and old-aged individuals
332 downloads 1.0 EPAD Administrator3 30-11-2020
“Ready for What” Timing and Speculation in Alzheimer’s Disease Drug Development
191 downloads 1.0 EPAD Administrator3 22-04-2021
LinkedInGoogle+